Chinanews.com, Wuhan, November 11 (Wu Yili Cheng Zhengmao Dai Peiwen) The second World Health Expo opened in Wuhan on the 11th. 27 major health industry projects were signed on-site, covering medical technology, gene sequencing, industrial technology research, etc. Multiple areas.
Among them, the team of academician Yu Jinming of the Chinese Academy of Engineering and the team of Martin focused on tumor research, and signed the “Wuhan Optics Valley Oncology New Technology Research Institute” project and the “Wuhan Gynecological Oncology Technology Research Institute” project; Chinese Academy of Sciences academician Ding Han focused on improving Wuhan Medical technology, signed the "Huazhong University of Science and Technology-United Imaging Group Medical Technology Joint Laboratory" project.
In addition, "Digital Health Wuhan 2030 Double Headquarters", "Chinese Academy of Sciences Antiviral Vaccine Drug Industry Technology Research Institute", "Concord Proton Radiotherapy System Procurement" and other major health industry projects have been signed.
In July of this year, Wuhan issued the "Academicians and Experts Leading Ten High-end Industry Development Action Plan", clarifying 47 academicians and 37 experts to participate in industry leadership.
The city plans to build ten high-end industrial clusters with core technological advantages, a complete innovation chain, strong radiation effects, and a leading domestic level by 2025, including the big health industry.
Yang Xiaoming, Chairman of Sinopharm Group China Biotech, expressed the hope that with the World Health Expo as an opportunity, the group's subsidiary in Han China can make greater contributions to the development and driving of the biological industry in Wuhan and even Hubei Province.
It is understood that a total of 13,000 guests from 34 countries participated in this World Health Expo, with more than 1,200 exhibiting companies, including GE, Philips, Siemens, Johnson & Johnson and other leading health companies in the world, as well as Taikang Insurance Group, China Biotech, Fortune 500 companies such as Hengrui Pharmaceuticals.
"Well-known hospitals, experts and scholars, and representatives of Fortune 500 companies at home and abroad gathered in Wuhan to discuss the big health industry. Wuhan will surely build a world-class trillion-dollar health industry cluster and usher in its own development opportunities." World Health Organization Former Director General Margaret Chan said.
(Finish)